Jinli Wei

5.6k total citations
25 papers, 559 citations indexed

About

Jinli Wei is a scholar working on Cancer Research, Oncology and Infectious Diseases. According to data from OpenAlex, Jinli Wei has authored 25 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 6 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Jinli Wei's work include Breast Cancer Treatment Studies (5 papers), Multiple and Secondary Primary Cancers (3 papers) and Breast Lesions and Carcinomas (2 papers). Jinli Wei is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Multiple and Secondary Primary Cancers (3 papers) and Breast Lesions and Carcinomas (2 papers). Jinli Wei collaborates with scholars based in China, United States and Singapore. Jinli Wei's co-authors include Deyuan Fu, Yi‐Zhou Jiang, Chuanli Ren, Yulin Luo, Zhengquan Zhang, Zhimin Shao, Siyu Wu, Jing Li, Xi Jin and Xiao‐En Xu and has published in prestigious journals such as Chemosphere, Frontiers in Immunology and PLoS Computational Biology.

In The Last Decade

Jinli Wei

23 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinli Wei China 12 269 209 118 112 83 25 559
Jason Reeves United States 10 289 1.1× 128 0.6× 115 1.0× 91 0.8× 33 0.4× 24 566
Weiqi Nian China 15 351 1.3× 243 1.2× 169 1.4× 106 0.9× 45 0.5× 32 640
Lele Ye China 13 425 1.6× 290 1.4× 165 1.4× 71 0.6× 72 0.9× 27 776
Minggao Guo China 13 251 0.9× 166 0.8× 86 0.7× 38 0.3× 61 0.7× 27 523
Sanju Sinha United States 12 259 1.0× 106 0.5× 116 1.0× 68 0.6× 34 0.4× 28 507
Birte Möhlendick Germany 14 134 0.5× 162 0.8× 217 1.8× 155 1.4× 77 0.9× 32 502
Fengping Zheng China 13 386 1.4× 186 0.9× 51 0.4× 85 0.8× 51 0.6× 47 673
Sonia Cellot Canada 14 410 1.5× 79 0.4× 184 1.6× 64 0.6× 88 1.1× 44 787
Lin Gu China 16 274 1.0× 196 0.9× 100 0.8× 44 0.4× 202 2.4× 48 725

Countries citing papers authored by Jinli Wei

Since Specialization
Citations

This map shows the geographic impact of Jinli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinli Wei more than expected).

Fields of papers citing papers by Jinli Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinli Wei. The network helps show where Jinli Wei may publish in the future.

Co-authorship network of co-authors of Jinli Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jinli Wei. A scholar is included among the top collaborators of Jinli Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinli Wei. Jinli Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yangtao, Zijun Liu, Jinli Wei, et al.. (2024). Compensatory growth of Microcystis aeruginosa after copper stress and the characteristics of algal extracellular organic matter (EOM). Chemosphere. 352. 141422–141422. 2 indexed citations
3.
4.
Yang, Yang, Minghui Yang, Yun Peng, et al.. (2022). Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection. Nature Microbiology. 7(3). 423–433. 75 indexed citations
5.
Wei, Jinli, Siyu Wu, Yun‐Song Yang, et al.. (2021). GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002383–e002383. 41 indexed citations
6.
Wu, Siyu, Yi Xiao, Jinli Wei, et al.. (2021). MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002528–e002528. 62 indexed citations
7.
Li, Jin, Jinli Wei, Zhixiang Xu, et al.. (2021). Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression. Frontiers in Immunology. 12. 691879–691879. 16 indexed citations
8.
Zhang, Haiping, Yang Yang, Junxin Li, et al.. (2020). A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. PLoS Computational Biology. 16(12). e1008489–e1008489. 44 indexed citations
9.
Wei, Jinli, Yi‐Zhou Jiang, & Zhimin Shao. (2020). The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype. The Breast. 51. 40–49. 12 indexed citations
10.
11.
Li, Jin, Chuming Chen, Jinli Wei, et al.. (2019). Delayed peak of human infections and ongoing reassortment of H7N9 avian influenza virus in the newly affected western Chinese provinces during Wave Five. International Journal of Infectious Diseases. 88. 80–87. 3 indexed citations
12.
Wei, Jinli, Yi‐Zhou Jiang, & Zhimin Shao. (2019). Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study. International Journal of Clinical Oncology. 24(8). 934–940. 42 indexed citations
13.
Fu, Deyuan, Jing Li, Jinli Wei, et al.. (2018). HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer. Cell Communication and Signaling. 16(1). 8–8. 74 indexed citations
14.
Wei, Jinli, Jiaxin Zhang, & Deyuan Fu. (2018). Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. World Journal of Surgical Oncology. 16(1). 236–236. 10 indexed citations
15.
16.
Fu, Deyuan, et al.. (2018). PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α–Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer. Cellular Physiology and Biochemistry. 51(5). 2434–2444. 63 indexed citations
17.
Fu, Deyuan, et al.. (2015). Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer. Tumor Biology. 36(10). 8025–8034. 26 indexed citations
18.
19.
Wei, Jinli, Deyuan Fu, & Jiaxin Zhang. (2012). Sentinel lymph node biopsy in papillary thyroid cancer. 6(4). 240–242. 2 indexed citations
20.
Wei, Jinli & Mengmeng Zhang. (2008). Distributing Stations in a Given Urban Rail Transit Line. 440–443.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Reeves Breakdown of academic impact, for papers by Weiqi Nian Breakdown of academic impact, for papers by Lele Ye Breakdown of academic impact, for papers by Minggao Guo Breakdown of academic impact, for papers by Sanju Sinha Breakdown of academic impact, for papers by Birte Möhlendick Breakdown of academic impact, for papers by Fengping Zheng Breakdown of academic impact, for papers by Sonia Cellot Breakdown of academic impact, for papers by Lin Gu
Rankless by CCL
2026